Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2007 1
2015 2
2018 3
2019 2
2020 5
2021 3
2022 5
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.
van Rhee F, Voorhees P, Dispenzieri A, Fosså A, Srkalovic G, Ide M, Munshi N, Schey S, Streetly M, Pierson SK, Partridge HL, Mukherjee S, Shilling D, Stone K, Greenway A, Ruth J, Lechowicz MJ, Chandrakasan S, Jayanthan R, Jaffe ES, Leitch H, Pemmaraju N, Chadburn A, Lim MS, Elenitoba-Johnson KS, Krymskaya V, Goodman A, Hoffmann C, Zinzani PL, Ferrero S, Terriou L, Sato Y, Simpson D, Wong R, Rossi JF, Nasta S, Yoshizaki K, Kurzrock R, Uldrick TS, Casper C, Oksenhendler E, Fajgenbaum DC. van Rhee F, et al. Among authors: pierson sk. Blood. 2018 Nov 15;132(20):2115-2124. doi: 10.1182/blood-2018-07-862334. Epub 2018 Sep 4. Blood. 2018. PMID: 30181172 Free PMC article.
International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.
van Rhee F, Oksenhendler E, Srkalovic G, Voorhees P, Lim M, Dispenzieri A, Ide M, Parente S, Schey S, Streetly M, Wong R, Wu D, Maillard I, Brandstadter J, Munshi N, Bowne W, Elenitoba-Johnson KS, Fössa A, Lechowicz MJ, Chandrakasan S, Pierson SK, Greenway A, Nasta S, Yoshizaki K, Kurzrock R, Uldrick TS, Casper C, Chadburn A, Fajgenbaum DC. van Rhee F, et al. Among authors: pierson sk. Blood Adv. 2020 Dec 8;4(23):6039-6050. doi: 10.1182/bloodadvances.2020003334. Blood Adv. 2020. PMID: 33284946 Free PMC article.
Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.
Nishimura Y, Fajgenbaum DC, Pierson SK, Iwaki N, Nishikori A, Kawano M, Nakamura N, Izutsu K, Takeuchi K, Nishimura MF, Maeda Y, Otsuka F, Yoshizaki K, Oksenhendler E, van Rhee F, Sato Y. Nishimura Y, et al. Among authors: pierson sk. Am J Hematol. 2021 Oct 1;96(10):1241-1252. doi: 10.1002/ajh.26292. Epub 2021 Jul 28. Am J Hematol. 2021. PMID: 34265103 Free PMC article.
Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes.
Pierson SK, Lim MS, Srkalovic G, Brandstadter JD, Sarmiento Bustamante M, Shyamsundar S, Mango N, Lavery C, Austin B, Alapat D, Lechowicz MJ, Bagg A, Li H, Casper C, van Rhee F, Fajgenbaum DC. Pierson SK, et al. Blood Adv. 2023 Nov 14;7(21):6652-6664. doi: 10.1182/bloodadvances.2023010745. Blood Adv. 2023. PMID: 37656441 Free PMC article.
CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease.
Pierson SK, Katz L, Williams R, Mumau M, Gonzalez M, Guzman S, Rubenstein A, Oromendia AB, Beineke P, Fosså A, van Rhee F, Fajgenbaum DC. Pierson SK, et al. Nat Commun. 2022 Nov 24;13(1):7236. doi: 10.1038/s41467-022-34873-7. Nat Commun. 2022. PMID: 36433996 Free PMC article.
Emerging role of 18F-FDG PET/CT in Castleman disease: a review.
Koa B, Borja AJ, Aly M, Padmanabhan S, Tran J, Zhang V, Rojulpote C, Pierson SK, Tamakloe MA, Khor JS, Werner TJ, Fajgenbaum DC, Alavi A, Revheim ME. Koa B, et al. Among authors: pierson sk. Insights Imaging. 2021 Mar 11;12(1):35. doi: 10.1186/s13244-021-00963-1. Insights Imaging. 2021. PMID: 33709329 Free PMC article. Review.
Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review.
Fajgenbaum DC, Khor JS, Gorzewski A, Tamakloe MA, Powers V, Kakkis JJ, Repasky M, Taylor A, Beschloss A, Hernandez-Miyares L, Go B, Nimgaonkar V, McCarthy MS, Kim CJ, Pai RL, Frankl S, Angelides P, Jiang J, Rasheed R, Napier E, Mackay D, Pierson SK. Fajgenbaum DC, et al. Among authors: pierson sk. Infect Dis Ther. 2020 Sep;9(3):435-449. doi: 10.1007/s40121-020-00303-8. Epub 2020 May 27. Infect Dis Ther. 2020. PMID: 32462545 Free PMC article. Review.
Increased mTORC2 pathway activation in lymph nodes of iMCD-TAFRO.
Phillips AD, Kakkis JJ, Tsao PY, Pierson SK, Fajgenbaum DC. Phillips AD, et al. Among authors: pierson sk. J Cell Mol Med. 2022 Jun;26(11):3147-3152. doi: 10.1111/jcmm.17251. Epub 2022 Apr 30. J Cell Mol Med. 2022. PMID: 35488725 Free PMC article.
Increased mTOR activation in idiopathic multicentric Castleman disease.
Arenas DJ, Floess K, Kobrin D, Pai RL, Srkalovic MB, Tamakloe MA, Rasheed R, Ziglar J, Khor J, Parente SAT, Pierson SK, Martinez D, Wertheim GB, Kambayashi T, Baur J, Teachey DT, Fajgenbaum DC. Arenas DJ, et al. Among authors: pierson sk. Blood. 2020 May 7;135(19):1673-1684. doi: 10.1182/blood.2019002792. Blood. 2020. PMID: 32206779 Free PMC article.
Ongoing symptoms following complete surgical excision in unicentric Castleman disease.
Sarmiento Bustamante M, Shyamsundar S, Coren FR, Bagg A, Srkalovic G, Alapat D, van Rhee F, Lim MS, Lechowicz MJ, Brandstadter JD, Pierson SK, Fajgenbaum DC. Sarmiento Bustamante M, et al. Among authors: pierson sk. Am J Hematol. 2023 Nov;98(11):E334-E337. doi: 10.1002/ajh.27065. Epub 2023 Aug 28. Am J Hematol. 2023. PMID: 37635628 Free PMC article. No abstract available.
27 results